Back to Search Start Over

Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

Authors :
European Research Council
Instituto de Salud Carlos III
Pérez-Tur, Jordi [0000-0002-9111-1712]
European Alzheimer’s & Dementia Biobank Mendelian Randomization (EADB-MR)
Luo, Jiao
Thomassen, Jesper Qvist
Bellenguez, Celine
Grenier-Boley, Benjamin
Rojas, Itziar de
Castillo, Atahualpa
Parveen, Kayenat
Kucukali, Fahri
Nicolas, Aude
Peters, Oliver
Schneider, Anja
Dichgans, Martin
Rujescu, Dan
Scherbaum, Norbert
Jurgen, Deckert
Riedel-Heller, Steffi
Hausner, Lucrezia
Molina Porcel, Laura
Duzel, Emrah
Grimmer, Timo
Wiltfang, Jens
Heilmann-Heimbach, Stefanie
Moebus, Susanne
Tegos, Thomas
Scarmeas, Nikolaos
Clarimón, Jordi
Moreno, Fermín
Pérez-Tur, Jordi
Bullido, Maria J.
Pastor, Pau
Sánchez-Valle, Raquel
Álvarez, Victoria
Boada, Mercè
García-González, Pablo
Puerta, Raquel
Mir, Pablo
Real, Luis Miguel
Piñol-Ripoll, Gerard
García-Alberca, José María
Royo, José Luis
Rodríguez-Rodríguez, Eloy
Soininen, Hilkka
Kuulasmaa, Teemu
Mendonça, Alexandre de
Mehrabian, Shima
Hort, Jakub
Vyhnalek, Martin
van der Lee, Sven
Graff, Caroline
Papenberg, Goran
Giedraitis, Vilmantas
Boland, Anne
Bacq-Daian, Delphine
Deleuze, Jean-Francois
Nicolas, Gael
Dufouil, Carole
Pasquier, Florence
Hanon, Olivier
Debette, Stephanie
Grunblatt, Edna
Popp, Julius
Benussi, Luisa
Galimberti, Daniela
Arosio, Beatrice
Mecocci, Patrizia
Solfrizzi, Vincenzo
Parnetti, Lucilla
Squassina, Alessio
Tremolizzo, Lucio
Borroni, Barbara
Nacmias, Benedetta
Sorbi, Sandro
Caffarra, Paolo
Seripa, Davide
Rainero, Innocenzo
Daniele, Antonio
Masullo, Carlo
Spalletta, Gianfranco
Williams, Julie
Amouyel, Philippe
Jessen, Frank
Kehoe, Patrick
Magda, Tsolaki
Rossi, Giacomina
Sánchez-Juan, Pascual
Sleegers, Kristel
Ingelsson, Martin
Andreassen, Ole A.
Hiltunen, Mikko
Van Duijn, Cornelia
Sims, Rebecca
van der Flier, Wiesje
Ruiz, Agustín
Ramírez, Alfredo
Lambert, Jean-Charles
Frikke-Schmidt, Ruth
European Research Council
Instituto de Salud Carlos III
Pérez-Tur, Jordi [0000-0002-9111-1712]
European Alzheimer’s & Dementia Biobank Mendelian Randomization (EADB-MR)
Luo, Jiao
Thomassen, Jesper Qvist
Bellenguez, Celine
Grenier-Boley, Benjamin
Rojas, Itziar de
Castillo, Atahualpa
Parveen, Kayenat
Kucukali, Fahri
Nicolas, Aude
Peters, Oliver
Schneider, Anja
Dichgans, Martin
Rujescu, Dan
Scherbaum, Norbert
Jurgen, Deckert
Riedel-Heller, Steffi
Hausner, Lucrezia
Molina Porcel, Laura
Duzel, Emrah
Grimmer, Timo
Wiltfang, Jens
Heilmann-Heimbach, Stefanie
Moebus, Susanne
Tegos, Thomas
Scarmeas, Nikolaos
Clarimón, Jordi
Moreno, Fermín
Pérez-Tur, Jordi
Bullido, Maria J.
Pastor, Pau
Sánchez-Valle, Raquel
Álvarez, Victoria
Boada, Mercè
García-González, Pablo
Puerta, Raquel
Mir, Pablo
Real, Luis Miguel
Piñol-Ripoll, Gerard
García-Alberca, José María
Royo, José Luis
Rodríguez-Rodríguez, Eloy
Soininen, Hilkka
Kuulasmaa, Teemu
Mendonça, Alexandre de
Mehrabian, Shima
Hort, Jakub
Vyhnalek, Martin
van der Lee, Sven
Graff, Caroline
Papenberg, Goran
Giedraitis, Vilmantas
Boland, Anne
Bacq-Daian, Delphine
Deleuze, Jean-Francois
Nicolas, Gael
Dufouil, Carole
Pasquier, Florence
Hanon, Olivier
Debette, Stephanie
Grunblatt, Edna
Popp, Julius
Benussi, Luisa
Galimberti, Daniela
Arosio, Beatrice
Mecocci, Patrizia
Solfrizzi, Vincenzo
Parnetti, Lucilla
Squassina, Alessio
Tremolizzo, Lucio
Borroni, Barbara
Nacmias, Benedetta
Sorbi, Sandro
Caffarra, Paolo
Seripa, Davide
Rainero, Innocenzo
Daniele, Antonio
Masullo, Carlo
Spalletta, Gianfranco
Williams, Julie
Amouyel, Philippe
Jessen, Frank
Kehoe, Patrick
Magda, Tsolaki
Rossi, Giacomina
Sánchez-Juan, Pascual
Sleegers, Kristel
Ingelsson, Martin
Andreassen, Ole A.
Hiltunen, Mikko
Van Duijn, Cornelia
Sims, Rebecca
van der Flier, Wiesje
Ruiz, Agustín
Ramírez, Alfredo
Lambert, Jean-Charles
Frikke-Schmidt, Ruth
Publication Year :
2023

Abstract

Importance: An estimated 40% of dementia is potentially preventable by modifying 12 risk factors throughout the life course. However, robust evidence for most of these risk factors is lacking. Effective interventions should target risk factors in the causal pathway to dementia. Objective: To comprehensively disentangle potentially causal aspects of modifiable risk factors for Alzheimer disease (AD) to inspire new drug targeting and improved prevention. Design, setting, and participants: This genetic association study was conducted using 2-sample univariable and multivariable mendelian randomization. Independent genetic variants associated with modifiable risk factors were selected as instrumental variables from genomic consortia. Outcome data for AD were obtained from the European Alzheimer & Dementia Biobank (EADB), generated on August 31, 2021. Main analyses were conducted using the EADB clinically diagnosed end point data. All analyses were performed between April 12 and October 27, 2022. Exposures: Genetically determined modifiable risk factors. Main outcomes and measures: Odds ratios (ORs) and 95% CIs for AD were calculated per 1-unit change of genetically determined risk factors. Results: The EADB-diagnosed cohort included 39 106 participants with clinically diagnosed AD and 401 577 control participants without AD. The mean age ranged from 72 to 83 years for participants with AD and 51 to 80 years for control participants. Among participants with AD, 54% to 75% were female, and among control participants, 48% to 60% were female. Genetically determined high-density lipoprotein (HDL) cholesterol concentrations were associated with increased odds of AD (OR per 1-SD increase, 1.10 [95% CI, 1.05-1.16]). Genetically determined high systolic blood pressure was associated with increased risk of AD after adjusting for diastolic blood pressure (OR per 10-mm Hg increase, 1.22 [95% CI, 1.02-1.46]). In a second analysis to minimize bias due to sample overlap, the entire UK

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1395198184
Document Type :
Electronic Resource